GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Beam Therapeutics BEAM · USD

Health Care · US listing · 🇺🇸 United States

Compare

27.02

+2.31%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Beam Therapeutics and similar listings

Same market and sector, closest in size

Name Last closeMarket valueP/ENet marginYield Change
Beam Therapeutics BEAM 27.02$2.75bn—-57.2%— +2.31%
WAVE Life Sciences WVE 3.48$586.9m—-478.3%— +3.26%
Immunome IMNM 19.36$2.14bn—-3060.0%— +3.47%
Travere Therapeutics TVTX 51.63$4.07bn—-5.2%— +4.09%
Dyne Therapeutics DYN 18.62$3.01bn—15.0%— +3.04%
LifeStance Health Group LFST 14.60$5.71bn575.20.7%— +6.03%
Neogen NEOG 12.08$2.62bn—-0.9%— +2.72%
Arcus Biosciences RCUS 18.95$2.33bn—-142.9%— +3.67%
Premier PINC 49.41$4.54bn62.32.0%1.63% -0.02%

Closes are in the currency each stock trades in. Blank figures mean we hold no company data for that listing yet.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.